Deletions of RPS12 are frequently observed in diffuse large B cell lymphomas [242], and eS12 has been reported to play a role as a stimulator of WNT secretion in cancer cells, which is particularly important in the context of triple-negative breast cancer initiation and progression [243]. Here, RPS12 is linked to triple-negative breast carcinoma.